Filing Details

Accession Number:
0001437749-14-009081
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-14 17:10:54
Reporting Period:
2014-05-09
Filing Date:
2014-05-14
Accepted Time:
2014-05-14 17:10:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389545 Novabay Pharmaceuticals Inc. NBY Pharmaceutical Preparations (2834) 680454536
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1593299 Ltd Holdings Pharma Pioneer China 190 Elgin Ave
Georgetown
Grand Cayman, Cayman Islands KY1-9005
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-09 318,828 $0.99 426,984 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,005,656 Indirect By Pioneer Pharma (Singapore) Pte Ltd
Footnotes
  1. The shares are held by Pioneer Pharma (Singapore) Pte Ltd, which is a wholly owned subsidiary of Pioneer Pharma (Hong Kong) Company Limited, which is a wholly owned subsidiary of the Reporting Person.